Zimmer Biomet Announces Third Quarter 2026 Financial Results
Article excerpt
Highlighted: the sentence this signal was extracted from
WARSAW, Ind., Nov. 4, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2026. The Company reported third quarter net sales of $2.063 billion, an increase of 3.1% over the prior year period and an increase of 3.7% on a constant currency 1 basis. Net earnings for the third quarter were $191.6 million, or $362.8 million on an adjusted 1 basis. Diluted earnings per share were $1.00 for the third quarter, a decrease of 13.8%, and adjusted 1 diluted earnings per share were $1.90, consistent with the prior year period. Zimmer Biomet generated $560.0 million in operating cash flow and $372.4 million of free cash flow 1 in the third quarter. ____________________ 1 Reconciliations of these non-GAAP measures to the corresponding U.S. generally accepted accounting principles measures are included in this press release. "We are very pleased with our solid third quarter results, growing net sales 3.7% on a constant-currency basis and generating strong operating and free cash flow," said Ivan Tornos, Chairman, President and CEO of Zimmer Biomet. "Our Hips, S.E.T. and Technology & Data, Bone Cement and Surgical franchises – representing two-thirds of our book of business – grew at upper single digit or double-digit rates, validating the progress of our diversification strategy, the strength of our...
Keep reading with a free account
The rest of this article, and every signal for Zimmer Biomet, is in your free account.
